**Core Concept**
Erythropoietin (EPO) is a renal hormone that plays a crucial role in regulating red blood cell production in response to hypoxia. When oxygen levels in the body decrease, such as at high altitudes, EPO stimulates the proliferation and survival of early erythroid progenitor cells in the bone marrow.

**Why the Correct Answer is Right**
EPO promotes the survival of early erythroid progenitor cells primarily through the inhibition of apoptosis. Apoptosis, or programmed cell death, is a mechanism by which cells undergo self-destruction in response to various signals, including DNA damage or hypoxia. EPO binds to its receptor on the surface of early erythroid progenitor cells, initiating a signaling cascade that inhibits the activation of pro-apoptotic proteins and promotes the expression of anti-apoptotic proteins. This leads to the survival and proliferation of these cells, resulting in increased red blood cell production.

**Why Each Wrong Option is Incorrect**
* **Option A:** Altered cell-matrix adhesion is not a primary mechanism by which EPO promotes the survival of early erythroid progenitor cells. While cell-matrix adhesion can influence cell survival and proliferation, it is not directly involved in EPO-mediated erythropoiesis.
* **Option B:** Downregulation of p53 is not a mechanism by which EPO promotes the survival of early erythroid progenitor cells. p53 is a tumor suppressor protein that promotes apoptosis in response to DNA damage or other forms of cellular stress. EPO does not directly downregulate p53 to promote cell survival.
* **Option C:** Enhanced glucose uptake is not a primary mechanism by which EPO promotes the survival of early erythroid progenitor cells. While glucose is essential for cell survival and proliferation, EPO does not primarily promote glucose uptake to stimulate erythropoiesis.

**Clinical Pearl / High-Yield Fact**
EPO is a critical hormone that regulates red blood cell production in response to hypoxia. Understanding the mechanisms by which EPO promotes the survival of early erythroid progenitor cells is essential for clinicians to diagnose and manage conditions related to erythropoiesis, such as anemia and polycythemia.

**✓ Correct Answer: D. Inhibition of apoptosis.**